The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study
Open accessAbstract
OBJECTIVES: Although evidence is growing on the overall impact of the COVID-19 pandemic on tuberculosis (TB) services, global studies based on national data are needed to better quantify the extent of the impact and the countries' preparedness to tackle the two diseases. The aim of this study was to compare the number of people with new diagnoses or recurrence of TB disease, the number of drug-resistant (DR)-TB, and the number of TB deaths in 2020 vs 2019 in 11 countries in Europe, Northern America, and Australia. METHODS: TB managers or directors of national reference centers of the selected countries provided the agreed-upon variables through a validated questionnaire on a monthly basis. A descriptive analysis compared the incidence of TB and DR-TB and mortality of the pre-COVID-19 year (2019) vs the first year of the COVID-19 pandemic (2020). RESULTS: Comparing 2020 vs 2019, lower number of TB cases (new diagnosis or recurrence) was notified in all countries (except USA-Virginia and Australia), and fewer DR-TB notifications (apart from France, Portugal, and Spain). The deaths among TB cases were higher in 2020 compared to 2019 in most countries with three countries (France, The Netherlands, USA-Virginia) reporting minimal TB-related mortality. CONCLUSIONS: A comprehensive evaluation of medium-term impact of COVID-19 on TB services would benefit from similar studies in multiple settings and from global availability of treatment outcome data from TB/COVID-19 co-infected patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Previously described disruptions in tuberculosis services and treatment in Russia and Brazil might have led to increases in tuberculosis mortality.
“This analysis provides some indication that previously described disruptions in tuberculosis services and treatment in both Russia78, 79 and Brazil80 might have led to increases in tuberculosis mortality.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases
Tadolini, M., Codecasa, L. R., García-García, J.-M., Blanc, F. –., Borisov, S. E., Alffenaar, J. C., Andréjak, C., Bachez, P., Bart, P., Belilovski, E., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01398-2020 · Cited by 409
Self-citationThe impact of COVID-19 on TB: a review of the data
McQuaid, C. F., Vassall, A., Cohen, T., Fiekert, K., COVID/TB Modelling Working Group *, & White, R. G. (2021) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.21.0148 · Cited by 335
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020
Migliori, G. B., Thong, P. M., Akkerman, O. W., Alffenaar, J. C., Álvarez-Navascués, F., Neino, M. M. A., Bernard, P. V., Biala, J. S., Blanc, F. –., Bogorodskaya, E. M., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2611.203163 · Cited by 218
Self-citationGauging the impact of the COVID-19 pandemic on tuberculosis services: a global study
Migliori, G. B., Thong, P. M., Alffenaar, J.-W., Denholm, J., Tadolini, M., Alyaquobi, F., Blanc, F.-X., Buonsenso, D., Cho, J.-G., Codecasa, L. R., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.01786-2021 · Cited by 155
Self-citationTuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe?
Silva, D. R., Mello, F. C. D. Q., D’Ambrosio, L., et al. (2021) · Jornal Brasileiro de Pneumologia · doi:10.36416/1806-3756/e20210044 · Cited by 44
Self-citationImpact of the COVID-19 pandemic on tuberculosis services
Rodrigues, I., Aguiar, A., Migliori, G. B., et al. (2022) · Pulmonology · doi:10.1016/j.pulmoe.2022.01.015 · Cited by 40
Self-citationMigliori, G. B., Thong, P. M., Alffenaar, J. C., et al. (2022) · Jornal Brasileiro de Pneumologia · doi:10.36416/1806-3756/e20220087 · Cited by 30
Self-citationThe scientific response to TB – the other deadly global health emergency
Chaisson, R. E., Frick, M. W., & Nahid, P. (2022) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.21.0734 · Cited by 22
COVID-19 Hampered Diagnosis of TB Infection in France, Italy, Spain and the United Kingdom
García-García, J.-M., Blanc, F. –., Buonsenso, D., Centis, R., Codecasa, L. R., D’Ambrosio, L., Goletti, D., Gualano, G., Kunst, H., Pontali, E., et al. (2022) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2022.07.013 · Cited by 10
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Ledesma, J. R., Ma, J., Zhang, M., Basting, A. V. L., Chu, H. T., Vongpradith, A., Novotney, A., LeGrand, K. E., Xu, Y. Y., Dai, X., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00007-0 · Cited by 146
Metadata
- Authors
- Nalunjogi, J., Mucching-Toscano, S., Sibomana, J. P., Centis, R., D'Ambrosio, L., Alffenaar, J.-W., Denholm, J., Blanc, F.-X., Borisov, S., Danila, E., Duarte, R., García-García, J.-M., Goletti, D., Ong, C. W. M., Rendon, A., Thomas, T. A., Tiberi, S., van den Boom, M., Sotgiu, G., & Migliori, G. B.
- Affiliations
- Sociedad Española de Neumología y Cirugía Torácica (ES)
- University of Rwanda (RW)
- Istituti Clinici Scientifici Maugeri (IT)
- The University of Sydney (AU)
- The Royal Melbourne Hospital (AU)
- Centre Hospitalier Universitaire de Nantes (FR)
- Central Scientific Research Institute of Tuberculosis Russian Academy of Medical Sciences (RU)
- Vilnius University (LT)
- Universidade do Porto (PT)
- Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani (IT)
- National University of Singapore (SG)
- University of Virginia (US)
- National Health Service (GB)
- University of Sassari (IT)
- Corresponding author
- Nalunjogi, Joanitah
- Sibomana, Jean Pierre
- Centis, Rosella
- Alffenaar, Jan-Willem
- Denholm, Justin
- Blanc, François-Xavier
- Borisov, Sergey
- Danila, Edvardas
- Duarte, Raquel
- García-García, José-María
- Goletti, Delia
- Ong, Catherine W.M.
- Thomas, Tania A.
- Tiberi, Simon
- Sotgiu, Giovanni
- Migliori, Giovanni Battista
- ORCID
- Nalunjogi, Joanitah
- Mucching-Toscano, Sergio
- Sibomana, Jean Pierre
- Centis, Rosella
- D'Ambrosio, Lia
- Alffenaar, Jan-Willem
- Denholm, Justin
- Blanc, François-Xavier
- Danila, Edvardas
- Duarte, Raquel
- García-García, José-María
- Goletti, Delia
- Ong, Catherine W.M.
- Thomas, Tania A.
- Tiberi, Simon
- van den Boom, Martin
- Sotgiu, Giovanni
- Migliori, Giovanni Battista
- Venue
- International Journal of Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2023-05
- Volume
- 130
- Pages
- S25-S29
- ISSN
- 1201-9712 (ISSN-L)
- PMC
- PMC9991328
- OpenAlex
- W4323349461
- Cited by
- 35
- References
- 9
- Citations by year
- 2026: 1 · 2025: 11 · 2024: 17 · 2023: 6
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Infectious Diseases (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by-nc-nd)
- Funders
- Universidade do Porto
- Centre hospitalier universitaire Sainte-Justine
- American Thoracic Society
- QIAGEN
- Rijksuniversiteit Groningen
- Ministero della Salute
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
- Keywords
- COVID-19 pandemic, tuberculosis, multidrug-resistant tuberculosis, tuberculosis diagnosis, tuberculosis mortality, tuberculosis incidence, tuberculosis notification, health system preparedness
- MeSH terms
- COVID-19, COVID-19 Testing, Antitubercular Agents, Europe, Humans, North America, Tuberculosis, Miliary, Tuberculosis, Multidrug-Resistant, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
